-
Cardiac death and perioperative myocardial infarctions occur in 2-20% (mean 6) of major noncardiac vascular surgery. Statins have been shown to have a protective effect, but the exact mechanism of this benefit is unclear.
-
Lesley and colleagues analyzed a 5% national sample of Medicare inpatient, outpatient, and carrier files to examine the use of ICD therapy for both primary and secondary prevention of sudden cardiac death.
-
-
Use of statins is associated with reduced rate of deterioration of lung function with aging, though the effect is reduced in those who continue to smoke.
-
Exceptional attention has been paid to the recent publication of the COURAGE Trial (April 2007) regarding the efficacy of percutaneous coronary intervention (PCI) in stable coronary disease patients.
-
The FDA has approved a new antimicrobial agent from the carbapenem class. Carbapenems are broad spectrum, beta lactam, antimicrobial agents.
-
Over half of patients with atrial fibrillation are over age 75 years, yet there is concern about the risk of serious hemorrhage in these patients on warfarin. Thus, the results of the Birmingham Atrial Fibrillation Treatment of the Aged (BAFTA) study are of interest.
-
Collaborative efforts between faculties of medicine and theater can be effective in teaching clinical empathy.
-
Benefits of Coronary Prevention: WOSCOPS, Topiramate for Alcohol Dependence, and Job Strain and Recurrent CHD
-
Withdrawal of statin therapy in acute ischemic stroke may lead to increases in death and disability.
